Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the use of a sequential high dose
chemotherapy is more effective than conventional dose (i.e. 4 cycles of cisplatin, etoposide,
and bleomycin [PEB]) in patients with metastatic poor prognosis germ cell tumors.
Phase:
Phase 2
Details
Lead Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano